Clopidogrel Tablet Manufacturer Supplier Exporter

Description

Clopidogrel Tablets 75 mg

Manufactured by: Healthy Life Pharma Pvt. Ltd. (WHO-GMP Certified)
Exported by: Healthy Inc (Star Export House)

1. Product Introduction

Healthy Life Pharma Pvt. Ltd. is a manufacturer, supplier and exporter of Clopidogrel Tablets in India. Clopidogrel is an antiplatelet medicine used to reduce the risk of harmful arterial blood-clot formation in appropriately selected patients. We support Clopidogrel 75 mg formulations and, where registered, fixed-dose Clopidogrel plus Aspirin combinations for cardiovascular therapy.

2. Product Specifications

3. Manufacturing and Quality Control

• Content Uniformity: Validated blending and compression controls support consistent Clopidogrel content in each dosage unit.
• Film Coating: Coating parameters are controlled according to the registered formulation and stability requirements.
• Combination Products: Clopidogrel + Aspirin formulations require validated compatibility, assay and dissolution controls for both active ingredients.
• Quality Testing: Assay, dissolution, related substances, dosage-unit uniformity and other applicable finished-product tests are performed against approved specifications.

4. How Clopidogrel Works

Clopidogrel is converted in the body to an active metabolite that irreversibly inhibits the platelet P2Y12 ADP receptor. This reduces platelet activation and aggregation and therefore helps lower the risk of arterial thrombotic events in appropriate patients.

5. Clinical Uses

• Cardiovascular / Cerebrovascular Risk Reduction: Used in selected patients with established atherosclerotic disease or acute coronary syndromes according to approved indications.
• After Coronary Intervention: May form part of antiplatelet therapy after coronary stent placement according to cardiology guidance.
• Clopidogrel + Aspirin: Dual antiplatelet therapy is appropriate only for selected indications and durations because it increases bleeding risk.

6. Export and Regulatory Support

• Dossier Support: CTD / ACTD documentation where applicable.
• Certificates: FSC, COPP and COA where applicable.
• Logistics: International air or sea shipment according to destination-market and regulatory requirements.

7. Frequently Asked Questions

Q: Who manufactures Clopidogrel Tablets?
A: Healthy Life Pharma Pvt. Ltd. manufactures Clopidogrel tablet formulations in India.

Q: What is Clopidogrel used for?
A: It reduces platelet aggregation and is prescribed to reduce the risk of certain heart attack, stroke and other arterial clotting events in appropriate patients.

Q: Can Clopidogrel and Aspirin be taken together?
A: They are prescribed together for selected cardiovascular indications, but the combination increases bleeding risk and should be used only under medical supervision.

Q: Should Clopidogrel be stopped before surgery?
A: Do not stop it on your own. The prescriber and surgeon should determine whether and when interruption is appropriate because stopping antiplatelet therapy can also increase clotting risk.

Clinical Pharmacology & Safety Information

(For Registered Medical Practitioners & Patient Reference)

8. Dosage and Administration

• Dose: Dose, loading strategy and treatment duration depend on the cardiovascular indication and approved prescribing information.
• Combination Therapy: Aspirin co-therapy and duration of dual antiplatelet treatment should be determined by the treating clinician.
• Administration: Follow the instructions for the registered product and prescribed treatment plan.

9. Side Effects and Precautions

• Bleeding: Clopidogrel increases bleeding risk. Unusual bruising, prolonged bleeding, blood in urine/stool or other significant bleeding requires medical assessment.
• Surgery / Procedures: Healthcare professionals should be informed that the patient takes an antiplatelet medicine before procedures.
• Drug Interactions: Concomitant anticoagulants, NSAIDs, other antiplatelet agents and certain medicines can further alter bleeding risk or Clopidogrel activity.
• CYP2C19: Clopidogrel requires metabolic activation; genetic variation and certain CYP2C19-inhibiting medicines can reduce antiplatelet effect.
• Rare Serious Reaction: Thrombotic thrombocytopenic purpura (TTP) is rare but requires urgent medical treatment.

10. Storage Instructions

• Store according to the registered product label, generally in a dry place protected from excessive heat and moisture.
• Keep in the original packaging until use.
• Keep out of reach of children.